Kentaro Minagawa

Kentaro Minagawa is an Assistant Professor in the Division of Hematology and Oncology at Penn State Cancer Institute. His research focuses on refining allogeneic stem cell transplantation strategies for hematological malignancies, particularly acute myeloid leukemia and graft-versus-host disease (GvHD) management.

• Key Research Areas: Allogeneic Hematopoietic Stem Cell Transplantation, GvHD, Leukemia Immunotherapy, Post-Transplant Complications, Dendritic Cell Engineering.

His recent work explores cytotoxic lymphocyte engineering, novel preconditioning regimens (e.g., clofarabine and post-transplant cyclophosphamide), and the impact of splenomegaly on transplant outcomes. Publications highlight collaborations across hematology, oncology, and immunology disciplines.

Minagawa’s research aligns with UN Sustainable Development Goals addressing health and well-being (SDG3) through advancements in cancer treatment. His work has been cited extensively in Scopus, reflecting significant contributions to hematological malignancies and transplantation medicine.